Download the app
App StorePlay Store
Beige
Login
← All tags

healthcare

India’s first CAR T therapy NexCAR 19 shows promise as hospitals expand treatment nationwide

India’s first CAR T therapy NexCAR 19 shows promise as hospitals expand treatment nationwide

India’s first CAR T cell therapy, NexCAR 19, is delivering encouraging early results for a specific blood cancer. Now available at 40 hospitals, the indigenous developer ImmunoACT is scaling access and building confidence in homegrown advanced treatment. The big question: can this breakthrough meaningfully change outcomes in the fight against cancer’s toughest battles?

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
How an Indian state is tackling cancer with a smarter care model

How an Indian state is tackling cancer with a smarter care model

As cancer diagnoses rise across India, particularly among younger people, one small state has rolled out a distinct care model aimed at earlier screening and faster treatment. The approach focuses on timely therapeutic intervention to improve outcomes, including better disease-free survival. The initiative highlights how organized cancer management can change the trajectory for patients facing an aggressive disease curve.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Your news, in seconds

App StorePlay Store
Indian pharma giant joins the weight loss race with a new obesity drug find

Indian pharma giant joins the weight loss race with a new obesity drug find

Weight-loss drugs have become a high-stakes global opportunity, and now a major Indian pharma player is stepping into the obesity fight with a fresh drug development. The move signals intensifying competition as companies chase demand for effective treatments, where speed to scale, manufacturing reach, and clinical promise could decide who leads the next wave of obesity medicines worldwide.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Orchid Pharma rebounds as its first novel antibiotic wins US and EU approvals

Orchid Pharma rebounds as its first novel antibiotic wins US and EU approvals

Orchid Pharma, once abandoned by investors, is hitting a major milestone with its first novel antibiotic drug. The company outlicensed the experimental therapy to Germany’s Allecra Therapeutics, which has now secured crucial approvals from the US FDA and a European drug regulator. Developed by Indian scientists in 2008, the breakthrough aims to strengthen the global fight against bacterial infections.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Ranjan Pai bets big on senior care and signals a USD30 billion opportunity

Ranjan Pai bets big on senior care and signals a USD30 billion opportunity

Influential investor Ranjan Pai has reportedly moved into senior care, putting the spotlight on a fast-growing sector framed as a possible USD30 billion opportunity. The development also raises questions about how capital could influence both formal healthcare capacity and the often-ignored grey economy around ageing services.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Healthcare and pharma jobs to surge by 2030 as tech reshapes hiring

Healthcare and pharma jobs to surge by 2030 as tech reshapes hiring

A new Adecco India report says India’s healthcare and pharmaceutical sector is shifting into capability-led growth, with job creation projected to reach 2–2.5 million by 2030. Hiring is moving toward specialised roles and deeper technology integration across hospitals, telemedicine, diagnostics, clinical research, AYUSH, and elder and home care.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Never miss a story

App StorePlay Store
Ivory’s AI brain treadmill test could spot early cognitive decline with benchmarked scores

Ivory’s AI brain treadmill test could spot early cognitive decline with benchmarked scores

AI startup Ivory is building a “treadmill test” for the brain, using cognitive assessments to measure attention, memory, and executive function. It plans to provide benchmarked scores and actionable insights that clinicians can use to distinguish early cognitive decline from lifestyle-driven issues. Ivory has partnered with Metropolis Healthcare and is in talks with diagnostic chains, insurers, and wellness platforms like Ultrahuman.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Hospital stocks shrug off volatility as insurance demand and bed expansion power profits

Hospital stocks shrug off volatility as insurance demand and bed expansion power profits

Hospital stocks are holding up even as markets swing, backed by faster EBITDA growth than revenue. Over FY2019-20 to FY2024-25, sector revenues rose around 15.5% annually while EBITDA grew about 25%. Analysts point to steadier cash flows from insurance-led payments, strong demand for profitable inpatient care, and aggressive expansion plans that add more beds and facilities.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Marengo Asia Hospitals plans 10% stake sale to raise ₹500 crore at ₹5,000 crore valuation

Marengo Asia Hospitals plans 10% stake sale to raise ₹500 crore at ₹5,000 crore valuation

Marengo Asia Hospitals is looking to raise ₹500 crore by selling a 10% stake, putting its valuation at about ₹5,000 crore. Backed by Samara Capital and promoter families tied to Godrej and Havells India, the chain runs eight hospitals across regions. The capital will fund further expansion, including acquisitions to grow its network.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Bajaj Group puts 2500 crore into healthcare, betting on hospitals clinics and home care

Bajaj Group puts 2500 crore into healthcare, betting on hospitals clinics and home care

Bajaj Group is entering healthcare with an initial Rs 2,000–2,500 crore investment to launch Bajaj Integrated Health Systems (BIHS). The company plans to offer an integrated continuum of care, combining hospitals, day clinics, and home services, with an ambition to expand across India in the next 10–15 years.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Reading on mobile?

App StorePlay Store
True North pumps Rs 150 crore into ACN Healthcare to accelerate expansion and new delivery facilities

True North pumps Rs 150 crore into ACN Healthcare to accelerate expansion and new delivery facilities

True North Private Equity’s Credit Opportunities Fund I is investing Rs 150 crore in ACN Healthcare RCM, a revenue cycle management provider. The funding is set to support the company’s growth plans, expand its services, and establish new delivery facilities. The deal underscores investor appetite for scaling healthcare operations through RCM capabilities.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Max Healthcare ramps beds to 6500 in Saket as demand for private care surges

Max Healthcare ramps beds to 6500 in Saket as demand for private care surges

Max Healthcare says hospital infrastructure alone won’t guarantee better patient outcomes, even as it expands capacity. The company has added a new facility in Saket, taking bed strength to about 6,500. It targets domestic patients and international medical tourists while using brownfield economics to control costs and narrow India’s private tertiary care bed gap.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
India medical tourism falls below pre covid peak as visas and geopolitics bite

India medical tourism falls below pre covid peak as visas and geopolitics bite

India’s medical tourism has slipped below its pre-Covid high, with industry citing geopolitical tensions, slow or delayed visas, and tougher competition from other Asian destinations. Leaders argue the way back is to sharpen high-tech capabilities and ensure reliable patient care. They also point to improving ties with Bangladesh as a potential boost to international arrivals.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Jharkhand to recruit 1200 doctors soon and upgrade CT MRI across hospitals

Jharkhand to recruit 1200 doctors soon and upgrade CT MRI across hospitals

Jharkhand plans to recruit over 1,200 doctors to strengthen healthcare delivery. The state will also rope in an external agency to manage blood supply. CT scan and MRI facilities are set to be installed in all medical colleges and district hospitals, alongside efforts to ramp up testing for sickle cell anaemia and thalassemia, with tuberculosis targeted for elimination by 2029.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Follow your favourite sources

App StorePlay Store
Maharashtra makes living wills digital first in India for faster end of life care decisions

Maharashtra makes living wills digital first in India for faster end of life care decisions

Maharashtra plans to digitize Living Will records through a new portal on mahaulb.in, letting citizens permanently store their medical treatment preferences. The move is designed to remove real-world delays at end-of-life moments and provide clearer, legally backed guidance for families and care providers. Municipal officials will serve as custodians to securely maintain and enable access to these documents.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Bain Capital emerges as sole contender to buy Vitabiotics after rivals exit bidding

Bain Capital emerges as sole contender to buy Vitabiotics after rivals exit bidding

Bain Capital has become the frontrunner to acquire Vitabiotics after TPG Capital and EQT exited the bidding process. The move could reduce the company’s expected valuation of about £900 million. Vitabiotics, founded in 1971, is the UK’s largest multivitamin maker and sells across markets including India and China, with its India business contributing around 20% of revenue.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
US House bill seeks to scrap 100000 H1B fee for doctors and nurses

US House bill seeks to scrap 100000 H1B fee for doctors and nurses

A bipartisan bill in the US House would waive a steep $100,000 H-1B visa fee for foreign doctors and nurses. The charge was introduced earlier and could raise hospital costs, especially at facilities already stretched thin. With the US facing a major doctor shortage, the proposal aims to help bring more medical professionals into care, including in rural and underserved communities.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Aster DM Healthcare invests Rs 96 crore to expand Whitefield maternity and pediatric care

Aster DM Healthcare invests Rs 96 crore to expand Whitefield maternity and pediatric care

Aster DM Healthcare has earmarked Rs 96 crore to expand the women and children facility at Aster Whitefield Hospital in Bengaluru. The upgrade is set to significantly raise inpatient capacity, aiming to strengthen specialized maternity and pediatric services for better maternal and child health outcomes in the region. The company also signals continued growth in Bengaluru.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Stay informed on the go

App StorePlay Store
Premji Invest backs NewEra Hospitals to scale advanced care and jump to 800 beds

Premji Invest backs NewEra Hospitals to scale advanced care and jump to 800 beds

Premji Invest has taken a stake in NewEra Hospitals to fund a major expansion. The plan is to raise capacity from 350 beds across three hospitals to 800 beds, while scaling advanced specialty care across Maharashtra. NewEra also expects to add three new hospitals in Nagpur, aiming to improve access to high-complexity treatment.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
KKR backed Baby Memorial to buy 60% of Star Hospitals for ₹1800 crore deal

KKR backed Baby Memorial to buy 60% of Star Hospitals for ₹1800 crore deal

KKR-backed Baby Memorial Hospital plans to acquire about a 60% stake in Unimed Healthcare, the parent company of Hyderabad hospital chain Star Hospitals, for around ₹1,800 crore. The deal would give Baby Memorial controlling interest, expanding its footprint in the regional healthcare market while consolidating ownership at the parent level.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Page 1

The full experience is on mobile.

Swipe through stories, personalise your feed, and save articles for later — all on the app.

Download on the App StoreGet it on Google Play